UCB Showcases Key Rheumatology Data at ACR Convergence 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NYSE: UCB) | Delayed: 36.91 -0.21 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.12 | 52 Week High | $ | |||
| Open | $37.24 | 52 Week Low | $ | |||
| Day High | $37.24 | P/E | N/A | |||
| Day Low | $36.46 | EPS | $ | |||
| Volume | 217,957 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 149.66 -0.99 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.65 | 52 Week High | $46.25 | |||
| Open | $148.69 | 52 Week Low | $32.74 | |||
| Day High | $150.50 | P/E | N/A | |||
| Day Low | $148.69 | EPS | $0.00 | |||
| Volume | 12,851 | |||||
